Page last updated: 2024-08-16

rbi 257 and l 745870

rbi 257 has been researched along with l 745870 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hopkins, CR; Lindsley, CW1
Bonifazi, A; Cifani, C; Del Bello, F; Fontana, S; Giorgioni, G; Mammoli, V; Matucci, R; Micioni Di Bonaventura, MV; Petrelli, R; Piergentili, A; Quaglia, W; Vistoli, G; Yano, H1

Reviews

1 review(s) available for rbi 257 and l 745870

ArticleYear
Return of D
    Journal of medicinal chemistry, 2017, 09-14, Volume: 60, Issue:17

    Topics: Animals; Drug Discovery; Humans; Ligands; Molecular Targeted Therapy; Neoplasms; Parkinson Disease; Receptors, Dopamine D4; Small Molecule Libraries; Substance-Related Disorders

2017

Other Studies

1 other study(ies) available for rbi 257 and l 745870

ArticleYear
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D
    Journal of medicinal chemistry, 2018, 04-26, Volume: 61, Issue:8

    Topics: Animals; Brain; CHO Cells; Cricetulus; Dopamine Antagonists; Drug Design; Guinea Pigs; HEK293 Cells; Humans; Ligands; Male; Mice; Molecular Docking Simulation; Piperidines; Quinolones; Rats; Receptors, Dopamine D4

2018